Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta

Ohad Etzion, Saeed Hamid, Tarik Asselah, George Sebastian Gherlan, Adela Turcanu, Tsarynna Petrivna, Lisa A. Weissfeld, Ingrid Choong, Colin Hislop, David Apelian, Marı́a Buti, Liana Gheorghe, Elena Laura Iliescu, Н. В. Воронкова, Natalia Barsukova, Soo Aleman, Jordan J. Feld, Nancy Reau, Maurizia Rossana Brunetto, Pietro Lampertico, Theo Heller, Chris Koh, Cihan Yurdaydın, Jeffrey S. Glenn